Literature DB >> 19301660

Synthetic microRNA targeting glioma-associated antigen-1 protein.

Naotake Tsuda1, Takahi Mine, Constantin G Ioannides, David Z Chang.   

Abstract

The transcription factor glioma-associated antigen-1 (Gli-1) mediates activation of the sonic hedgehog (Shh) pathway, a process that precedes the transformation of tissue stem cells into cancerous stem cells and that is involved in early and late epithelial tumorigenesis. Hypothesizing that targeting the 3'-untranslated region (3'-UTR) of Gli-1 mRNA would effectively inhibit epithelial tumor cell proliferation, we evaluated several complementary miRNA molecules for their ability to do so. The synthetic miRNAs and corresponding duplex/small temporal RNAs were introduced as 3-nucleotide (nt) loops into GU-rich portions of the 3'UTR Gli-1 sequence. One particular miRNA (miRNA Gli-1-3548) and its corresponding duplex (Duplex 3548) significantly inhibited proliferation of Gli-1+ ovarian (SK-OV-3) and pancreatic (MiaPaCa-2) tumor cells by delaying cell division and activating late apoptosis in MiaPaCa-2 cells. Here, we describe the design of effective miRNA sequences and their applications as anti-gene agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301660     DOI: 10.1007/978-1-60327-547-7_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents.

Authors:  Marta Olejniczak; Paulina Galka-Marciniak; Katarzyna Polak; Andrzej Fligier; Wlodzimierz J Krzyzosiak
Journal:  RNA       Date:  2012-03-12       Impact factor: 4.942

Review 2.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

Review 3.  MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.

Authors:  Satyanarayana Rachagani; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2009-12-09       Impact factor: 8.679

4.  Non-coding RNAs: a key to future personalized molecular therapy?

Authors:  Marco Galasso; Maria Elena Sana; Stefano Volinia
Journal:  Genome Med       Date:  2010-02-18       Impact factor: 11.117

Review 5.  MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.

Authors:  Jeongeun Hyun; Youngmi Jung
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

6.  MicroRNAs and Gastroenterological Cancers.

Authors:  Anuradha Budhu; Xin W Wang
Journal:  Drug Discov Today Dis Mech       Date:  2011-12-11

Review 7.  The clinical potential of microRNAs.

Authors:  Anuradha Budhu; Junfang Ji; Xin W Wang
Journal:  J Hematol Oncol       Date:  2010-10-06       Impact factor: 17.388

Review 8.  Risk factors and therapeutic targets in pancreatic cancer.

Authors:  Sonja Maria Wörmann; Hana Algül
Journal:  Front Oncol       Date:  2013-11-18       Impact factor: 6.244

Review 9.  Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.

Authors:  Tao Sun; Xiangyu Kong; Yiqi Du; Zhaoshen Li
Journal:  Gastroenterol Res Pract       Date:  2014-05-08       Impact factor: 2.260

Review 10.  MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

Authors:  Oronzo Brunetti; Antonio Russo; Aldo Scarpa; Daniele Santini; Michele Reni; Alessandro Bittoni; Amalia Azzariti; Giuseppe Aprile; Sabina Delcuratolo; Michele Signorile; Antonio Gnoni; Loredana Palermo; Vito Lorusso; Stefano Cascinu; Nicola Silvestris
Journal:  Oncotarget       Date:  2015-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.